1[1]Laffel LM,McGill JB,Gans DJ.The beneficial effect of ACE inhibition with Captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria.North American Microabluminura Study Group[J].Am J Med,1995,99(5):497-504.
3[3]Maric C,Aldfred GP,Antoine AM,et al.Effects of angiotensin Ⅱ on cultrued rat renomedullary interstitial cells are mediated by AT1A receptor[ J ].Am J Pbysiol,1996,271 (4):F1020-F1028.
4[4]Nahman NsJR,Rothe KL,Falkenhain ME,et al.Angiotensin Ⅱ induction of fibronection biosynthesis in cultrued human mesangial cells:association with CREB transcription factor action[J].J Lab Clin Med,1996,127 (6):599-611.
5[5]Ishidoya S,Morrisey J,MeCracken R,et al.Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy[ J ].Kidney Int,1996,49 (7):1110-1119.
6[6]Kagami S,Kuhara T,Okada K,et al.Dual effects of angiotensin Ⅱ on the plasminogen/plasmin system in rat mesangial cells[ J].Kidney Int,1997,51(6):664-671.
7[7]Oikawa T,Freeman M,Lo W,et al.Modulation of plasminogen activator inhibitor-1 in vivo:a new mechanism for the anti-fibrotic effect of reninangiotensin inhibition[J].Kidney Int,1997,51 (1):164-172.
8[8]Geiger H,Fierlbeck W,Mai M,et al.Effects of early and late antihypertensive treatment on extracellular matrix proteins and mononuclear cells in uninephrectomized SHR[ J ].Kidney Int,1997,51 (7):750-761.
9[9]Wolf G,Ziyadeh FN,Thaiss F,et al.Angiotensin Ⅱ stimulates expression of the chemokine RANTES in rat glomerular endothelial cells.Role of the angiotensin type 2 receptor[ J].J Clin Invest,1997,100(10):1047-1058.
10[10]Ruiz-Ortega M,Bustos C,Egido J.Angiotensin Ⅱ triggers monocyte MCP-1,TGF-β 1 and matrix protein gene expression in mesangial cells and interstitial renal fibroblasts[ J ].Nephrol Dial Transplant,1996,11 (2):A58-62.
同被引文献21
1Ellis D, Vats A,Moritz ML, et al.Long-term antiproteinuric and renoprotective efficacy and safety of Iosartan in children with proteinuria [ J ]. J Pediatr, 2003,143( 1 ) : 89-97.
2White CF, Macpherson CF, Hurley RM, et al. Antiproeinuric effects of enalapril and losartan:a pilot study[J]. Pediatr Nephrol,2003,18(10) : 1038-1043.
3Tylicki L, Renke M, Rutkowski P, et al. Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis[J]. Med Sci Monit, 2005, 11(4) : PI31-37.
4Renke M,Tylicki L, Rutkowski P, et al. Low-dose angiotensin Ⅱ receptor antagonists and angiotensin Ⅱ-convertlng enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis[J]. Seand J Urol Nephrol,2004,38(5) :427--433.
5Praga M.Therapeutic measures in proteinuric nephropathy[J]. Kidney Int Suppl,2005, (99) :S137-141.
6Wolf G, Ritz E. Combination therapy with ACE inhibitors and angiotensin Ⅱ receptor blockers to halt progression of chronic renal disease: pathophysiology and indications[J]. Kidney Int,2005,67(3) :799-812.
7Yang Y, Ohta K, Shimizu M, et al.Treatment with low-dose angiotensinconverting enzyme inhibitor (ACE1) plus angiotensin Ⅱ receptor blocker (ARB) in pediatric patients with IgA nephropathy[J]. Clin Nephrol, 2005,64(1) :35-40.
8Dixit MP, Dixit NM, Scott K, et al. Managing Henoeh-Schonlein purpura in children with fish oil and ACE inhibitor therapy[J]. Nephrology, (Carlton), 2004,9(6) :381-386.
9Bagga A, Mudigoudar BD, Hari P, et al. Enalapril dosage in steroidresis resistant nephrotic syndrome[J]. Pediatr Nephrol, 2004,19( 1 ) : 45-50.
10Ellis D, Moritz ML, Vats A, et al. Antihypertensive and renoprotective efficacy and safety of losartan: A long-term study in children with renal disorders[J]. Am J Hypertens,2004, 17(10) :928-935.
